Oct 21, 4:15 PM ET
Medpace reported third quarter 2026 revenue of $716.0 million, up 8.5%, and GAAP diluted earnings of $4.84 per share, up from $3.86 a year earlier. The company also replaced its prior buyback, which had $527.0 million remaining, with a new authorization of up to $1.0 billion of common stock through December 31, 2028, funded from cash on hand.
- Q3 2026 revenue $716.0 million, up 8.5% from $659.9 million; net new business awards $873.4 million, up 10.6%
- Q3 2026 GAAP net income $137.5 million ($4.84 per diluted share) vs. $111.1 million ($3.86) a year earlier; EBITDA $172.1 million, up 16.0%
- New repurchase authorization of up to $1.0 billion through December 31, 2028, effective October 20, 2026, replacing the prior authorization with $527.0 million remaining
- The filing gives 2026 full-year guidance of $2.835 billion to $2.855 billion in revenue and $17.97 to $18.32 in diluted EPS, with no prior guidance included for comparison
Read the filing on SEC.gov ↗
Jul 22, 4:15 PM ET
Medpace reported second quarter 2026 revenue of $707.3 million, up 17.2% from a year earlier, and GAAP net income of $121.4 million, or $4.25 per diluted share, compared with $3.10 a year earlier. The company also forecast full-year 2026 revenue of $2.805 billion to $2.885 billion and diluted EPS of $17.25 to $17.95.
- Q2 2026 revenue $707.3 million, up 17.2% from $603.3 million in Q2 2025
- Q2 2026 GAAP net income $121.4 million ($4.25 diluted EPS) vs. $90.3 million ($3.10) a year earlier
- Q2 2026 net new business awards $795.7 million, up 28.2%; book-to-bill ratio 1.13x
- Full-year 2026 guidance: revenue $2.805 billion to $2.885 billion; GAAP net income $494.0 million to $514.0 million
Read the filing on SEC.gov ↗
Jun 4, 4:06 PM ET
Medpace Holdings appointed Brad W. Hansman, age 43, as Executive Vice President, Operations, effective June 1, 2026. He will perform the functions of the company's principal operating officer alongside Susan E. Burwig, the current Executive Vice President, Operations. The filing discloses a $492,250 base salary and incentive eligibility, which is a routine leadership change for shareholders.
- Brad W. Hansman, age 43, appointed Executive Vice President, Operations, effective June 1, 2026
- Hansman will share principal operating officer duties with Susan E. Burwig
- Annual base salary of $492,250, plus eligibility for short-term incentive and long-term equity plans
Read the filing on SEC.gov ↗
Apr 22, 4:15 PM ET
Medpace reported first quarter 2026 revenue of $706.6 million, up 26.5% from a year earlier, and GAAP diluted earnings of $4.28 per share, up from $3.67. Net income margin fell to 17.5% from 20.5%, and the company set full-year 2026 revenue guidance of $2.755 billion to $2.855 billion. President Jesse Geiger also notified the company he will retire effective May 31, 2026, and CEO August Troendle will assume the president role until a successor is appointed.
- Q1 2026 revenue $706.6 million, up 26.5% from $558.6 million; GAAP net income $123.9 million, or $4.28 per diluted share, versus $114.6 million, or $3.67, a year earlier
- Q1 2026 EBITDA $149.4 million, up 25.9%; net income margin 17.5% versus 20.5% in Q1 2025
- 2026 guidance: revenue $2.755 billion to $2.855 billion; GAAP diluted EPS $16.68 to $17.50
- Jesse Geiger to retire as President effective May 31, 2026; not due to any disagreement with the company
Read the filing on SEC.gov ↗
Briefs are written by AI from the filing text (each brief's own page names the model) and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the model's reading of the filing for shareholders, not a price forecast. Not investment advice.